becoming a better Clinician
Pulmonary Embolism / Venous Thromboembolism
last updated: March 25, 2016
General
-
Risk Factors
-
Epidemiology
-
Prevention (in hospital)
-
SCDs
-
DVT prophylaxis
-
heparin 5000 SC qday bid/tid
-
lovenox 40mg SC qday; 30mg SC qday (GFR <30)
-
-
Pathophysiology
-
Virchow's triad
Diagnosis
-
ABG
-
CXR
-
Hampton's hump
-
Westermark's sign
-
-
EKG
-
D-dimer
-
brain natriuretic peptide
-
troponin T or I
-
Lower extremity ultrasound
-
venography
-
ECHO
-
right ventricular dilation
-
high tricuspid jet tells you how severe the clot burden is
-
not used to diagnose PE
-
-
V/Q scan
-
nuclear medicine scan (Xenon gas, Tc99m)
-
low probability < 20% PE
-
intermediate probability 20-80% PE
-
high probability > 80% PE
-
pneumonia or any CXR abnormalities impair this test
-
good for impaired kidney function
-
-
CT angio chest (test of choice)
-
looking for vascular filling deficits
-
-
Pulmonary angiogram (gold standard)
-
the most accurate test
-
-
-
almost never dones, dangerous
-
Treatment
-
anticoagulation
-
prevent further cloth formation
-
6-9 months of treatment
-
heparin (unfractionated)
-
80U/kg bolus, 18U/kg (PTT goal 60-90 sec)
-
can be turned off quickly
-
-
LMWH (SC) Enoxaparin (Lovenox)
-
1mg/kg SQ q12hours (q24 with impaired renal function <30 GFR)
-
low-molecular-weight heparin in cancer patients provides better VTE prophylaxis compared with vitamin K antagonists
-
-
warfarin (coumadin)
-
INR goal 2-3
-
many drug interactions
-
-
-
thrombolytic
-
dissolves the clot immediatly
-
-
IVC filter
-
used for GI bleed patients
-
allergic to heparin
-
failed anticoagulation (recurrent PE despite being anticoagulated)
-
proximal DVT with a massive PE
-
retrievable vs permanent IVC filters
-
retrievable for 3 months
-
-
complications
-
thrombosis
-
migration
-
tilting
-
penetration of vena cava wall
-
access site hematoma
-
infection
-
-
-
pulmonary embolectomy
-
ECMO